The Reading Hosp Med Ctr Reg Cancer Ctr — West Reading, Pennsylvania

The Reading Hosp Med Ctr Reg Cancer Ctr is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The Reading Hosp Med Ctr Reg Cancer Ctr has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Reading Hosp Med Ctr Reg Cancer Ctr?

The Reading Hosp Med Ctr Reg Cancer Ctr has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Reading Hosp Med Ctr Reg Cancer Ctr conducted?

The Reading Hosp Med Ctr Reg Cancer Ctr has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma.

Is The Reading Hosp Med Ctr Reg Cancer Ctr accredited by Crixeo Health?

The Reading Hosp Med Ctr Reg Cancer Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Reading Hosp Med Ctr Reg Cancer Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.